Bill Text: NY A11071 | 2019-2020 | General Assembly | Introduced


Bill Title: Relates to the dispensing of glucagon; authorizes a pharmacist to dispense any Food and Drug Administration approved glucagon medication to an insulin using person regardless if the person currently has or previously has had a prescription for glucagon.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2020-10-07 - referred to higher education [A11071 Detail]

Download: New_York-2019-A11071-Introduced.html



                STATE OF NEW YORK
        ________________________________________________________________________

                                          11071

                   IN ASSEMBLY

                                     October 7, 2020
                                       ___________

        Introduced  by  COMMITTEE ON RULES -- (at request of M. of A. Joyner) --
          read once and referred to the Committee on Higher Education

        AN ACT to amend the public health law, in relation to the dispensing  of
          glucagon

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. The public health law is amended by adding  a  new  section
     2  279-a to read as follows:
     3    §  279-a. Dispensing of glucagon. Notwithstanding any other provisions
     4  of law to the contrary, a pharmacist may  dispense  any  Food  and  Drug
     5  Administration  approved  glucagon medication to an insulin using person
     6  regardless  if  the  person  currently  has  or  previously  has  had  a
     7  prescription for glucagon.
     8    1.  (a) A health care professional may prescribe by a patient-specific
     9  or non-patient-specific prescription, dispense or  distribute,  directly
    10  or indirectly, an order of glucagon to a glucagon recipient;
    11    (b)  A  pharmacist  may  dispense  an  order  of  glucagon,  through a
    12  patient-specific or non-patient-specific prescription pursuant  to  this
    13  section, to a glucagon recipient;
    14    (c)  The  provisions  of this section shall not be deemed to require a
    15  prescription for any order of glucagon that does not otherwise require a
    16  prescription; nor shall it be deemed to limit the authority of a  health
    17  care  professional to prescribe, dispense or distribute, or of a pharma-
    18  cist to dispense, an order of glucagon under any other provision of law,
    19  provided that:
    20    (i) any dispensing of glucagon under this section shall be  done  only
    21  in  accordance  with a physician-approved protocol and shall specify the
    22  minimum required components of any such protocol;
    23    (ii) the person to whom glucagon is dispensed shall be educated by the
    24  pharmacist as to the mechanism and circumstances for the  administration
    25  of glucagon; and
    26    (iii)  a  record of the dispensing of glucagon shall be made available
    27  to the patient's physician and to the physician signing a protocol under
    28  this subdivision, if required by the physician or physicians.

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD17413-01-0

        A. 11071                            2

     1    2. Reimbursement is the responsibility of  the  person  obtaining  the
     2  glucagon  consistent  with  the requirements of his or her health insur-
     3  ance. The pharmacist shall counsel an uninsured person on  any  existing
     4  programs that aid in access to glucagon.
     5    § 2. This act shall take effect immediately.
feedback